Salem Investment Counselors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $220K | Buy |
494
+174
| +54% | +$77.5K | 0.01% | 357 |
|
2025
Q1 | $155K | Buy |
320
+61
| +24% | +$29.6K | 0.01% | 385 |
|
2024
Q4 | $104K | Hold |
259
| – | – | ﹤0.01% | 450 |
|
2024
Q3 | $120K | Hold |
259
| – | – | ﹤0.01% | 430 |
|
2024
Q2 | $121K | Buy |
259
+1
| +0.4% | +$469 | ﹤0.01% | 419 |
|
2024
Q1 | $108K | Hold |
258
| – | – | ﹤0.01% | 439 |
|
2023
Q4 | $105K | Sell |
258
-2
| -0.8% | -$814 | ﹤0.01% | 433 |
|
2023
Q3 | $90.4K | Buy |
260
+2
| +0.8% | +$695 | ﹤0.01% | 431 |
|
2023
Q2 | $90.8K | Hold |
258
| – | – | ﹤0.01% | 433 |
|
2023
Q1 | $81.3K | Buy |
258
+58
| +29% | +$18.3K | ﹤0.01% | 450 |
|
2022
Q4 | $57.8K | Hold |
200
| – | – | ﹤0.01% | 494 |
|
2022
Q3 | $58K | Buy |
+200
| New | +$58K | ﹤0.01% | 458 |
|
2022
Q1 | – | Sell |
-1,861
| Closed | -$409K | – | 1113 |
|
2021
Q4 | $409K | Buy |
1,861
+22
| +1% | +$4.84K | 0.01% | 292 |
|
2021
Q3 | $334K | Sell |
1,839
-2
| -0.1% | -$363 | 0.02% | 285 |
|
2021
Q2 | $371K | Buy |
1,841
+1,839
| +91,950% | +$371K | 0.02% | 270 |
|
2021
Q1 | $0 | Sell |
2
-17
| -89% | – | ﹤0.01% | 922 |
|
2020
Q4 | $4K | Buy |
+19
| New | +$4K | ﹤0.01% | 723 |
|
2019
Q3 | – | Sell |
-209
| Closed | -$38K | – | 672 |
|
2019
Q2 | $38K | Sell |
209
-1,690
| -89% | -$307K | ﹤0.01% | 407 |
|
2019
Q1 | $366K | Buy |
1,899
+5
| +0.3% | +$964 | 0.04% | 170 |
|
2018
Q4 | $314K | Sell |
1,894
-5
| -0.3% | -$829 | 0.04% | 164 |
|
2018
Q3 | $366K | Sell |
1,899
-235
| -11% | -$45.3K | 0.04% | 170 |
|
2018
Q2 | $363K | Hold |
2,134
| – | – | 0.03% | 168 |
|
2018
Q1 | $335K | Hold |
2,134
| – | – | 0.04% | 173 |
|
2017
Q4 | $320K | Buy |
2,134
+50
| +2% | +$7.5K | 0.03% | 179 |
|
2017
Q3 | $316K | Buy |
2,084
+1,870
| +874% | +$284K | 0.04% | 177 |
|
2017
Q2 | $28K | Buy |
+214
| New | +$28K | ﹤0.01% | 373 |
|